UK markets close in 3 hours 2 minutes

Relief Therapeutics Holding AG (0QKQ.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
0.0788+0.0006 (+0.77%)
As of 12:25PM GMT. Market open.
Full screen
Previous close0.0782
Open0.0798
Bid0.0000 x N/A
Ask0.0000 x N/A
Day's range0.0762 - 0.0802
52-week range0.0762 - 0.0802
Volume63,894
Avg. volumeN/A
Market cap49.955M
Beta (5Y monthly)-21.74
PE ratio (TTM)N/A
EPS (TTM)-0.0100
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • EQS Group

    Relief Reports US Collaboration Partner Announces Expansion of Aviptadil US Expanded Access & Right to Try Programs for Patients w/COVID-19 Respiratory Failure who've Exhausted All Approved Therapies

    RELIEF THERAPEUTICS Holding AG / Key word(s): Miscellaneous19-Jan-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Reports that its U.S. Collaboration Partner has Announced Expansion of Aviptadil U.S. Expanded Access and Right to Try Programs for Patients With COVID-19 Respiratory Failure who Have Exhausted All Approved TherapiesGeneva, Switzerland, January 19, 2022 - RELIEF THERAPEUTICS Hold

  • EQS Group

    Relief Therapeutics Comments on NRx Pharmaceuticals' Press Release Reporting on its Recently Filed Lawsuit

    RELIEF THERAPEUTICS Holding AG / Key word(s): Legal Matter14-Jan-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics Comments on NRx Pharmaceuticals' Press Release Reporting on its Recently Filed Lawsuit Geneva, Switzerland, January 14, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a biopharmaceutical company seeking to provide patients therapeuti

  • EQS Group

    Relief Comments on Lawsuit Filed Against It by NeuroRx

    RELIEF THERAPEUTICS Holding AG / Key word(s): Legal Matter12-Jan-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Comments on Lawsuit Filed Against It by NeuroRxGeneva, Switzerland, January 12, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need,